Mariah Butcher, FNP- C Write a description for this list item and include information that will interest site visitors
GLP-1s mimic these actions and, as theyre resistant to the enzyme DPP4, have a longer-lasting impact on our appetite
Cheng HW, Yang SF, Liao PL, Lee CH, Jong GP
Instead, it focuses on daily habits, nutrition targets, behavior change and long-term sustainability
Short-acting GLP-1 agonists like exenatide (taken twice daily) may produce more immediate effects on post-meal glucose levels, whilst longer-acting weekly formulations such as semaglutide or dulaglutide provide more sustained action but may take longer to reach steady-state concentrations in the body
The problem, however, is multifaceted